日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor

INCB086550 的特性分析:一种高效新型小分子 PD-L1 抑制剂

Holly K Koblish # ,Liangxing Wu # ,Liang-Chuan S Wang # ,Phillip C C Liu ,Richard Wynn ,Jonathan Rios-Doria ,Susan Spitz ,Hao Liu ,Alla Volgina ,Nina Zolotarjova ,Kanishk Kapilashrami ,Elham Behshad ,Maryanne Covington ,Yan-Ou Yang ,Jingwei Li ,Sharon Diamond ,Maxim Soloviev ,Kevin O'Hayer ,Stephen Rubin ,Chrysi Kanellopoulou ,Gengjie Yang ,Mark Rupar ,Darlise DiMatteo ,Luping Lin ,Christina Stevens ,Yue Zhang ,Pramod Thekkat ,Ryan Geschwindt ,Cindy Marando ,Swamy Yeleswaram ,Jeff Jackson ,Peggy Scherle ,Reid Huber ,Wenqing Yao ,Gregory Hollis

A Potent and Selective Dual Inhibitor of AXL and MERTK Possesses Both Immunomodulatory and Tumor-Targeted Activity

一种强效且选择性的AXL和MERTK双重抑制剂兼具免疫调节和肿瘤靶向活性

Jonathan Rios-Doria ,Margaret Favata ,Kerri Lasky ,Patricia Feldman ,Yvonne Lo ,Gengjie Yang ,Christina Stevens ,Xiaoming Wen ,Sarita Sehra ,Kamna Katiyar ,Ke Liu ,Richard Wynn ,Jennifer J Harris ,Min Ye ,Susan Spitz ,Xiaozhao Wang ,Chunhong He ,Yun-Long Li ,Wenqing Yao ,Maryanne Covington ,Peggy Scherle ,Holly Koblish

Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assays

溶液相桥接试验分级免疫原性检测中筛选结果与确认结果的相关性

Robert J Kubiak, Lanju Zhang, Jianchun Zhang, Yuan Zhu, Nancy Lee, Frank F Weichold, Harry Yang, Varghese Abraham, Peter F Akufongwe, Lisa Hewitt, Susan Robinson, Weiyi Liu, Xu Liu, Mun Mun Patnaik, Susan Spitz, Yuling Wu, Lorin K Roskos